[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertisement
Advertise Here
August 01, 2011
Volume 89, Number 31
p. 9

Stem Cells: NIH welcomes dismissal of lawsuit that would stop funding of research

Britt Erickson

  • Print this article
  • Email the editor

Latest News



October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

A federal judge has thrown out a case that in August 2010 briefly shut down government-funded research on human embryonic stem cells and threatened to stop the work altogether. The ruling clears the way for the National Institutes of Health to continue funding the controversial research.

Two scientists filed the lawsuit against NIH, claiming that the agency’s policy violates the Dickey-Wicker Amendment, a law that prohibits federal funding of any research that destroys human embryos. NIH countered that it funds research involving previously derived embryonic stem cells.

Chief Judge Royce C. Lamberth of the U.S. District Court for the District of Columbia ruled last August that the plaintiffs’ argument had merit and issued a preliminary injunction ordering NIH to stop funding human embryonic stem cell research. But a federal appeals court lifted the injunction in April, ruling that the law “does not extend to past actions” (C&EN, May 9, page 12). Saying his hands were tied by the appellate court’s decision, Lamberth dismissed the lawsuit on July 27.

Biomedical researchers and NIH officials were overjoyed by the lawsuit’s dismissal, saying it will allow groundbreaking research that could lead to cures and treatments for numerous diseases.

The litigation, however, is likely to continue. The plaintiffs plan to review all options for an appeal, according to their attorney, Steven H. Aden of the Alliance Defense Fund. “In these tough economic times, it makes no sense for the federal government to use taxpayer money for this illegal and unethical purpose,” Aden says.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!